Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00517829 · ClinicalTrials.gov registry record · Phase 2
Docetaxel+Oxali+/-Cetux Met Gastric/GEJ
A Phase 2 study, sponsored by US Oncology Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT00517829 is a Phase 2 study that has completed, run by US Oncology Research. The registered enrollment target is 150 participants.
The verdict
NCT00517829, a Phase 2 study, has completed, sponsored by US Oncology Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
The purpose of this research study is to find out what effects (good and bad) docetaxel, oxaliplatin, and cetuximab have on gastric or GEJ cancer.
Interventions
- DRUG Docetaxel
- DRUG cetuximab
- DRUG oxaliplatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2007-07 |
| Est. Completion | 2012-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00517829
The ClinicalTrials.gov registry entry for NCT00517829 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Oncology Research, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Docetaxel is the first listed.
NCT00517829 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00517829 about?
NCT00517829 is a clinical study titled "Docetaxel+Oxali+/-Cetux Met Gastric/GEJ". The purpose of this research study is to find out what effects (good and bad) docetaxel, oxaliplatin, and cetuximab have on gastric or GEJ cancer.
What is the current status of trial NCT00517829?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2007-07. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00517829?
The interventions under investigation include: Docetaxel (DRUG), cetuximab (DRUG), oxaliplatin (DRUG).
Who is sponsoring clinical trial NCT00517829?
This trial is sponsored by US Oncology Research, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.